MDWD - MediWound Ltd
IEX Last Trade
18.33
0.100 0.546%
Share volume: 49,928
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$18.23
0.10
0.55%
View ratios
Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
Report Date | 2022-08-09 | 2022-11-15 | 2023-03-16 | 2023-05-30 | 2023-08-15 | 2023-11-21 | 2024-03-21 | 2024-05-29 | |
Total revenue | 4.668 M | 5.803 M | 11.618 M | 3.799 M | 4.773 M | 4.776 M | 5.338 M | 4.964 M | |
Cost of revenue | 3.555 M | 3.369 M | 3.460 M | 2.973 M | 3.636 M | 3.880 M | 4.619 M | 4.357 M | |
Gross profit | 1.113 M | 2.434 M | 8.158 M | 826.000 K | 1.137 M | 896.000 K | 719.000 K | 607.000 K | |
118.69% | 235.17% | -89.87% | 37.65% | -21.20% | -19.75% | -15.58% | |||
Operating expenses | 4.478 M | 5.944 M | -1.260 M | 5.190 M | 5.144 M | 4.145 M | -2.168 M | 4.341 M | |
Selling general and admin | 2.287 M | 3.061 M | -3.959 M | 3.088 M | 3.120 M | 2.612 M | -3.976 M | 2.871 M | |
Research and development | 2.191 M | 2.883 M | 2.699 M | 2.102 M | 2.024 M | 1.533 M | 1.808 M | 1.470 M | |
Total expenses | 8.033 M | 9.313 M | 9.042 M | 8.163 M | 8.780 M | 7.801 M | 8.570 M | 8.698 M | |
15.93% | -2.91% | -9.72% | 7.56% | -11.15% | 9.86% | 1.49% | |||
Operating income | -3.365 M | -3.510 M | 2.576 M | -4.364 M | -4.007 M | -3.025 M | -3.232 M | -3.734 M | |
Ebit | -3.365 M | -3.510 M | 2.576 M | -4.364 M | -4.007 M | -3.025 M | -3.021 M | -3.734 M | |
Pretax income | -4.350 M | -4.194 M | -7.392 M | -3.688 M | 928.000 K | -2.148 M | -1.623 M | -9.705 M | |
-3.59% | 76.25% | -50.11% | -125.16% | -331.47% | -24.44% | 497.97% | |||
Income tax | 4.000 K | 5.000 K | 65.000 K | 5.000 K | 12.000 K | 48.000 K | 120.000 K | 24.000 K | |
Net income basic | -4.354 M | -4.199 M | -7.457 M | -3.693 M | 916.000 K | -2.196 M | -1.743 M | -9.729 M | |
3.56% | -77.59% | 50.48% | 124.80% | -339.74% | 20.63% | -458.18% | |||
Net income | -4.354 M | -4.199 M | -7.457 M | -3.693 M | 916.000 K | -2.196 M | -1.743 M | -9.729 M | |
3.56% | -77.59% | 50.48% | 124.80% | -339.74% | 20.63% | -458.18% |